All Episodes
|
142
|
Summer Knight

Podcast 142: Humanizing Health Care With Dr. Summer Knight

Apr 8, 2022

Episode Summary

We are thrilled to welcome Dr. Summer Knight, former firefighter/paramedic-turned primary care and emergency room doctor, managing director at Deloitte Consulting’s Life Sciences & Health Care practice, and author of Humanizing Healthcare! Dr. Knight shares her fascinating path of entrepreneurship, and dives deep into the transforming trends and key disruptors in healthcare today. Tune in to hear John and Dr. Knight elaborate on the impact therapeutic alliances can have within our healthcare ecosystem, highlighting the movement toward patient-centric care.

Episode Notes

Summer Knight, MD, MBA, a former firefighter/paramedic-turned primary care and emergency room doctor, is a Managing Director in Deloitte Consulting’s Life Sciences & Health Care practice.  She is a passionate advocate for humanizing healthcare, an innovative leader in digital and virtual health, and a pragmatic futurist who helps clients act upon today’s rapid changes in healthcare.

Dr. Knight maintains an active physician license, is board certified in family medicine and was Chief of Staff of a 4-hospital healthcare system and Emergency and Urgent Care Department Chair. She is an accomplished leader having held key executive positions in F100 Plan, Digital Health, Provider, Government and Private Equity.  She also has academic credentials having been an adjunct Professor and Executive-in-Residence for Healthcare at the Fox School of Business at Temple University. Her perspective on healthcare is informed not only by her professional experience, but also by her role as a patient and sandwich generation caregiver.

John Marchica, CEO, Darwin Research Group

John Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.

John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.

About Darwin Research Group

Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

CONNECT WITH US:

🌐 Visit us on the web

🌐 Follow Health Care Rounds on LinkedIn

🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube

🎧 Listen on Apple Podcasts

🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media

Recommended Next

Podcast 200: How Health Systems Build Elite Clinical Leaders w/ Dr. Jonathan Stallkamp, CMO, Main Line Health
Podcast 199: A New Blueprint for Rural Health Care w/ Natalie L. Baggio, President, Corewell Health South
Podcast 198: Standing Strong as an Independent Health System w/ Dr. Allen Smith & Dr. Sam Ash, South Shore Health
Podcast 197: Making Health Care Costs Simple and Transparent w/ Mark Cuban, Co-Founder, Cost Plus Drugs
Podcast 196: Physician Leadership in a New Era of Health Care w/ Dr. Sowmya Viswanathan, Baycare
Podcast 195: Why Primary Care Is Under Strain w/ Dr. Greg Whisman, Chief Medical Officer, CareMore Health
Podcast 194: Why Health Care Reform Keeps Failing w/ Dr. David Shulkin
Podcast 193: The New Model for Specialty Pharmacy w/ Jigar Thakkar, PharmD

Recommended Content

Browse Library
INsights
February 16, 2026

Darwin's Our Take: Feature: A rare FDA refusal, CDC grant cuts, and proposed ACA exchange changes

Read More
INsights
February 9, 2026

Darwin's Our Take: Lilly’s, Novo Nordisk’s share prices roller-coaster following earnings reports

Read More
INsights
February 2, 2026

Darwin's Our Take: Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations

Read More
Stay Aware. Stay Informed.

Subscribe to Our Take

Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.